Midsona AB Class B MSON_B

Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 134.2 million in the third quarter of 2026 (Q3 2025: NOK 134.1 million), and Adjusted EBITDA of NOK 18.5 million (Q3 2025: NOK 18.9 million). In 2026, Photocure now expects product revenue growth in the range of 10% to 12% on a constant currency basis (versus 8 to 11% previously) and adjusted EBITDA margin expansion.

Annual revenue for 2025–2026: -13.0%A fiscal year-end under pressure, held backby persistently weak markets Q4 revenue(July 2026–September 2026))2024–20252025–2026Change (reported)Change in LFL*ReportedReported€m%€m%AGRICULTURAL SPRAYING93.397.8+4.5 +4.8%+3.1+3.3%SUGAR BEET HARVESTING67.962.5-5.4-7.9%-5.1-7.5%LEISURE24.323.4-0.8-3.4%+0.2+1.0%INDUSTRY72.161.7-10.4-14.4%-11.1-15.3%EXEL Industries Group257.5245.4-12.1-4.7%-12.8-5.0% *LFL: like-for-like, i.e. at constant foreign exchange rates and s

Sanoma Corporation, Stock Exchange Release, 28 October 2026 at 8:30 a.m. EET Sanoma Corporation, Interim Report 1 January–30 September 2026: Strong growth in adjusted operating profit EARNINGS OUTLOOK FOR 2026 NARROWED TO THE HIGHER END This release is a summary of Sanoma’s Interim Report 1 January–30 September 2026. The complete report is attached to this release and is also available at www.sanoma.com/en/investors. Q3 2026 Net sales were stable in both businesses and the Group's net sales amou

AI focused tech stocks just grabbed the spotlight after SK hynix reported record earnings tied to heavy semiconductor demand, and that kind of growth story is exactly where insider backed high growth companies can attract attention. When founders and executives keep big stakes, their incentives line up with yours. This article highlights 3 fast growing, owner led stocks from our screener that fit that profile today. The three stocks highlighted here offer a compelling starting point if you...

Tieto Oyj walked into its Q3 2026 report with a flat 7 day return and only a small gain over the past month, priced at €18.9 and treated by many as a low multiple, low expectations stock. The headline was clear. Revenue landed at €397m while basic earnings per share came in at €0.37, and the group reported an adjusted EBITA margin that management placed in the mid teens. Against that backdrop, today’s muted share move looks less like excitement and more like investors wrestling with whether a...

Aspo Plc Investor news October 28, 2026 at 8.00 a.m. EETAspo to publish Interim Report on Monday, November 2, 2026Aspo Plc will publish its Interim Report for July-September 2026 on Monday, November 2, 2026, at approximately 9.00 a.m. EET. A news conference for analysts, investors and the media will be held at Sanomatalo, Flik Studio Eliel, Töölönlahdenkatu 2, Helsinki on November 2, 2026, at 12.00 p.m. The event is also open to private investors. Participants are requested to register beforehan

European natural gas prices have surged and British households are watching winter energy bills closely. That kind of pressure pushes investors to look harder at smaller UK listed businesses with cleaner balance sheets and sensible cash habits. This article focuses on a group of low priced shares that aim to combine penny stock upside with tighter financial risk controls. You will see three of the most financially disciplined options picked out and broken down. The three stocks highlighted...

Intrum’s latest analyst update centers on a lower fair value, with the price target reduced from SEK 5.47 to SEK 4.63, a cut of about 15% in the target valuation. Analysts link this move to refreshed assumptions in their models, which now feed into a revised target that reflects current thinking on Intrum’s outlook. In the sections that follow, you will see how this shift fits into the broader Intrum story and how to track the evolving narrative around the stock. Stay updated as the Fair...

Cardiologist and Bayer® Aspirin Partner Dr. Jayne Morgan Discusses Why Midlife Is an Important Time for Women to Focus on Their Heart Health Cardiologist and Bayer® Aspirin Partner Dr. Jayne Morgan Discusses Why Midlife Is an Important Time for Women to Focus on Their Heart Health NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Menopause often brings conversations surrounding reproductive health – but experts say there’s another important topic women shouldn’t overlook: heart health. Cardiovascular

LAVAL, France, October 27, 2026--Regulatory News: Séché Environnement (Paris:SCHP):

Dowa Holdings has had a strong multi year run, which puts a spotlight on whether the current share price lines up with what its earnings can reasonably support. With that backdrop, the real issue for you is whether the recent performance leaves enough earnings power on the table to justify paying today's price. The stock has returned 96.1% over the past 5 years, which raises the question of how much of Dowa Holdings' earnings strength may already be reflected in the valuation. The business...

VZ Holding has delivered a near doubling for long term shareholders over the past few years, which puts its current price under a sharper spotlight. The open question is whether that share performance lines up with the returns the business actually earns on the capital it deploys. Over the past 3 years, VZ Holding has returned about 99.7%, which raises the stakes on whether the underlying return on capital justifies that kind of share gain. The group’s valuation story now leans heavily on...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.